Fort Lee, New Jersey, USA, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Fort Lee, N.J. Januray 29, 2015 Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicines (Botanical Therapeutics®) announced today that its 2014 sales of AcnEase® proprietary acne treatment grew over 75% in comparison to 2013.
§ Sales for the first three Quarters of 2014 were 31% higher than TOTAL sales for 2013
§ Herborium expended its sales in UK through upgrading its distribution collaboration with HUT Group LLC., UK's and Europe leading multi-website online retailer of health and beauty products. Hut supports more than 140 million global website visitors, 5 million customers and 8 million orders dispatched worldwide across such on line stores as www.myprotein.com, www.LookFantastic.com, www.beautyexpert.co.uk, mankind.co.uk, and others.
§ AcnEase® has established itself as a leading natural acne treatment in France with an unprecedented support of French social media. French population is 64.6 million, which makes it the 2nd most populated country in the European Union. More than 23% of the population in France has acne for a total of 15 million people. Acne affects about 80% of teens (15% with severe acne), nearly 20% of women and 13.8% of men aged from 35 to 54 suffer from acne.
The French market is the 4th largest beauty market in the world and worth $ 7 billion. Skin care is the main beauty expense in France with 32% of the market and is also the fastest growing segment of the market.
§ AcnEase® US Social Media presence continued to grow at the rate of over 10% / quarter and Facebook "likes" surpassed 10,000.
§ AcnEase® has been featured at the BeautyPress Spotlight Event on September 24th 2014 in New York City, as one of only 10 top innovative products selected for exhibition.
The global revenues in acne market are $3 billion, and a steady growth of the market for acne therapeutics is expected to continue to 2018 with USA and EU only growing to over 120 million acne sufferers. Herborium is committed to continue growing its market share in its market and accelerate growth of revenues and profitability.
AcnEase® is a proprietary, all herbal formula that is up to 96% effective and can be successfully use by both women and men of all ages and color of complexion without sun restrictions or any adverse effects.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
Herborium Group, Inc.
CONTACT: Email: InvestorsRelations@Herborium.com tel. 201.849.4431
Source:Herborium Group, Inc.